Search Here

Bioquark, a U.S.-based company has their highly original research on the reanimation on brain dead patients handed out a green light by the Institutional Review Board in the U.S. and India. According to IFL Science, the biotech company will have an access to 20 clinically dead post-trauma patients in order for them to experiment if introducing stem cells to the central nervous system will bring them out of their vegetative state. Other procedures to be considered for the study will be the infusion of cocktail peptides to the spinal cord and nerve stimulation techniques.

Ira Pastor the CEO of Bioquark and their endeavor may be tagged as a straight-from-a-science-fiction-novel study and be taken for granted as performing a lost cause. However, Pastor has a capable team in his hands led by neurological researcher Dr. Calixto Machado. Machado is a noted medical fixture in the American Academy of Neurology and has authored a great amount on brain death.

Pastor remained adamant and pointed out, "To undertake such a complex initiative, we are combining biologic regenerative medicine tools with other existing medical devices typically used for stimulation of the central nervous system, in patients with other severe disorders of consciousness. We hope to see results within the first two to three months."

"It is a long-term vision of ours that a full recovery in such patients is a possibility, although that is not the focus of this first study. But it is a bridge to that eventuality," he added.

The trials which will all be administered at the Anupam Hospital in Rudrapur, Uttarakhand in India will also focus after the therapy on brain activity checking for the involved participants which will run for the next few months in order to assess for indications of neurological reactivation.

Machado and his team will concentrate more on the spinal cord as it is in charge in an individual's breathing and heart functions. The research has been set off by studies that implied that several electrical activity along with blood flow still persists after the collapse of the brain.